Roseola infantum and its causal human herpesviruses

International Journal of Dermatology

Volumn 53, Issue 4, 2014, Pages 397-403

  Stone, Rivka C ^a   Micali, Giuseppe A ^b   Schwartz, Robert A ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EXANTHEMA SUBITUM; HERPES VIRUS; HUMAN; HYDRATION; LABORATORY TEST; PATHOGENESIS; PROGNOSIS; REVIEW; VIRUS TRANSMISSION;

DIAGNOSIS, DIFFERENTIAL; EXANTHEMA SUBITUM; FEVER; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; SEIZURES;

EID: 84896490284     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12310     Document Type: Review

References (59)

1. Zahorsky J. Roseola infantilis. Pediatrics 1910; 22: 60-64.
2. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596-601.
3. Schwartz RA, Jagar C, Koziorynska EI. Human herpes virus 6. eMedicine from WebMD. Updated 2012. Available at: http://emedicine.com/derm/topic814.htm.
4. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065-1067.
5. Isegawa Y, Mukai T, Nakano K, et al. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 1999; 73: 8053-8063.
6. Nastke MD, Becerra A, Yin L, et al. Human CD4+ T cell response to human herpesvirus 6. J Virol 2012; 86: 4776-4792.
7. Dewhurst S, McIntyre K, Schnabel K, et al. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 1993; 31: 416-418.
8. Frenkel N, Schirmer EC, Wyatt LS, et al. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 1990; 87: 748-752.
9. Tanaka K, Kondo T, Torigoe S, et al. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994; 125: 1-5.
10. Huang LM, Lee CY, Liu MY, et al. Primary infections of human herpesvirus-7 and herpesvirus-6: a comparative, longitudinal study up to 6 years of age. Acta Paediatr 1997; 86: 604-608.
11. Caserta MT, Hall CB, Schnabel K, et al. Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr 1998; 133: 386-389.
12. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331: 432-438.
13. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992; 326: 1445-1450.
14. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768-776.
15. A. A. O. P. Committee on Infectious Diseases. Red Book: 2009 Report. USA: American Academy of Pediatrics, 2009.
16. Caserta MT, Mock DJ, Dewhurst S. Human herpesvirus 6. Clin Infect Dis 2001; 33: 829-833.
17. Berenberg W, Wright S, Janeway CA. Roseola infantum (exanthem subitum). N Engl J Med 1949; 241: 253-259.
18. Asano Y, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994; 93: 104-108.
19. Okuno T, Mukai T, Baba K, et al. Outbreak of exanthem subitum in an orphanage. J Pediatr 1991; 119: 759-761.
20. Santoro F, Kennedy PE, Locatelli G, et al. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99: 817-827.
21. Ward KN. Human herpesviruses-6 and -7 infections. Curr Opin Infect Dis 2005; 18: 247-252.
22. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170: 1586-1589.
23. De Araujo T, Berman B, Weinstein A. Human herpesviruses 6 and 7. Dermatol Clin 2002; 20: 301-306.
24. Mukai T, Yamamoto T, Kondo T, et al. Molecular epidemiological studies of human herpesvirus 6 in families. J Med Virol 1994; 42: 224-227.
25. Takahashi Y, Yamada M, Nakamura J, et al. Transmission of human herpesvirus 7 through multigenerational families in the same household. Pediatr Infect Dis J 1997; 16: 975-978.
26. Hall CB, Caserta MT, Schnabel KC, et al. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J Infect Dis 2010; 201: 505-507.
27. Hall CB, Caserta MT, Schnabel K, et al. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 2008; 122: 513-520.
28. Arbuckle JH, Medveczky MM, Luka J, et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci USA 2010; 107: 5563-5568.
29. Morissette G, Flamand L. Herpesviruses and chromosomal integration. J Virol 2010; 84: 12100-12109.
30. Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012; 22: 144-155.
31. Zahorsky J. Roseola infantum. JAMA 1913; 61: 1446-1450.
32. Stoeckle MY. The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease. Annu Rev Med 2000; 51: 423-430.
33. Kainth MK, Caserta MT. Molecular diagnostic tests for human herpesvirus 6. Pediatr Infect Dis J 2011; 30: 604-605.
34. Hashimoto H, Maruyama H, Fujimoto K, et al. Hematologic findings associated with thrombocytopenia during the acute phase of exanthem subitum confirmed by primary human herpesvirus-6 infection. J Pediatr Hematol Oncol 2002; 24: 211-214.
35. Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures. Pediatr Neurol 2006; 35: 165-172.
36. Ward KN. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 2005; 32: 183-193.
37. Bolle De L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005; 18: 217-245.
38. Peppercorn AF, Miller MB, Fitzgerald D, et al. High-level human herpesvirus-6 viremia associated with onset of Stevens-Johnson syndrome: report of two cases. J Burn Care Res 2010; 31: 365-368.
39. Razonable RR. Infections due to human herpesvirus 6 in solid organ transplant recipients. Curr Opin Organ Transplant 2010; 15: 671-675.
40. Gautheret-Dejean A. [HHV-6, HHV-7 and the kidney]. Nephrologie 2001; 22: 309-311.
41. Shiley K, Blumberg E. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Infect Dis Clin North Am 2010; 24: 373-393.
42. Caserta MT. Human herpesvirus 6 infection of the central nervous system. Curr Infect Dis Rep 2004; 6: 316-321.
43. Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol 2005; 124: 1234-1240.
44. Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol 2009; 61: 303-318.
45. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301-304.
46. Pritchett JC, Nanau RM, Neuman MG. The link between hypersensitivity syndrome reaction development and human herpes virus-6 reactivation. Int J Hepatol 2012; 2012: 723062.
47. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007; 157: 934-940.
48. Yoshikawa T, Akimoto S, Nishimura N, et al. Evaluation of active human herpesvirus 6 infection by reverse transcription-PCR. J Med Virol 2003; 70: 267-272.
49. Tait DR, Ward KN, Brown DW, et al. Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected]. BMJ 1996; 312: 101-102.
50. Segal AR, Doherty KM, Leggott J, et al. Cutaneous reactions to drugs in children. Pediatrics 2007; 120: e1082-e1096.
51. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I: clinical perspectives. J Am Acad Dermatol 2013; 68: 693-705.
52. Savolainen H, Lautenschlager I, Piiparinen H, et al. Human herpesvirus-6 and -7 in pediatric stem cell transplantation. Pediatr Blood Cancer 2005; 45: 820-825.
53. Clark DA, Griffiths PD. Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol 2003; 120: 384-395.
54. Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 595-598.
55. Magnoni M, Malnati M, Cristell N, et al. Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability. J Med Virol 2012; 84: 1961-1966.
56. Caselli E, Zatelli MC, Rizzo R, et al. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog 2012; 8: e1002951.
57. Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1, and -2, VZV. Am J Transplant 2004; 4(Suppl. 10): 66-71.
58. Bonnafous P, Bogaert S, Godet AN, et al. HDP-CDV as an alternative for treatment of human herpesvirus-6 infections. J Clin Virol 2013; 56: 175-176.
59. Gerdemann U, Keukens L, Keirnan JM, et al. Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood 2013; 121: 207-218.